Cost-Effectiveness of Maintenance bacillus Calmette-Guérin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer.

Overview of attention for article published in The Journal of Urology, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 27 X users

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 31 X posts from 27 X users, with an upper bound of 125,095 followers.

RT @MayoUrology: Thank you @JUrology! #BCG #blcsm #bladdercancer @KevinWymer @SBoorjian @MarkLitwinLA @UclaUrology @VigneshPackiam @HTho…

Thank you @JUrology! #BCG #blcsm #bladdercancer @KevinWymer @SBoorjian @MarkLitwinLA @UclaUrology @VigneshPackiam @HThompsonMD @jeffkarnesMD @MattTollefsonMD

#Bladdercancer Study supports @AmerUrological policy to allocate BCG for induction rather than maintenance therapy during times of BCG shortage. This would no doubt save the cost for our patients. @WorldBladderCan @BladderCaJrnl @BladderCa @SU2C @MoHFW_…

RT @JUrology: In era of BCG shortage, is maintenance BCG for intermediate & high risk NMIBC cost-effective? Markov results suggest prioriti…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 27 additional X posts.